Insider Transactions in Q3 2024 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
667
-0.4%
|
$4,669
$7.13 P/Share
|
|
Jul 21
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.67%
|
$1,939
$7.13 P/Share
|
|
Jul 21
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,372
-0.53%
|
$23,604
$7.13 P/Share
|
|
Jul 21
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
413
-1.07%
|
$2,891
$7.13 P/Share
|
|
Jul 21
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.62%
|
$2,765
$7.13 P/Share
|
|
Jul 20
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.43%
|
$5,019
$7.13 P/Share
|
|
Jul 20
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.6%
|
$1,757
$7.13 P/Share
|
|
Jul 20
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,982
-0.47%
|
$20,874
$7.13 P/Share
|
|
Jul 20
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.58%
|
$4,312
$7.13 P/Share
|
|
Jul 20
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.56%
|
$2,513
$7.13 P/Share
|
|
Jul 19
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,585
-1.49%
|
$18,095
$7.18 P/Share
|
|
Jul 19
2024
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,817
+0.59%
|
-
|
|
Jul 19
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,025
-1.57%
|
$7,175
$7.18 P/Share
|
|
Jul 19
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,307
-1.29%
|
$58,149
$7.18 P/Share
|
|
Jul 19
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.74%
|
$5,145
$7.18 P/Share
|
|
Jul 19
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-4.83%
|
$13,881
$7.18 P/Share
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-5.85%
|
$17,395
$7.4 P/Share
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
BUY
Exercise of conversion of derivative security
|
Direct |
4,439
+9.46%
|
-
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-3.57%
|
$11,662
$7.4 P/Share
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
5,677
+10.84%
|
-
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,730
-4.16%
|
$201,110
$7.4 P/Share
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,279
+7.54%
|
-
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,016
-2.26%
|
$28,112
$7.4 P/Share
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,142
+5.9%
|
-
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
2,379
-3.39%
|
$16,653
$7.4 P/Share
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+8.6%
|
-
|
|
Jul 17
2024
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+19.09%
|
-
|
|
Jul 17
2024
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+22.02%
|
-
|
|
Jul 17
2024
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
38,953
+18.84%
|
-
|
|
Jul 17
2024
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+35.34%
|
-
|
|
Jul 17
2024
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+12.09%
|
-
|
|
Jul 17
2024
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,811
+14.1%
|
-
|
|
Jul 17
2024
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+14.03%
|
-
|
|
Jul 17
2024
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+23.82%
|
-
|
|
Jul 17
2024
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
20,541
+19.04%
|
-
|
|
Jul 17
2024
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
12,350
+15.89%
|
-
|
|
Jul 17
2024
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
18,733
+30.71%
|
-
|
|
Jul 17
2024
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
21,971
+34.86%
|
-
|